MDGL
Price
$324.70
Change
+$17.62 (+5.74%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
7.08B
35 days until earnings call
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 21 closing price
Capitalization
884.73K
57 days until earnings call
Ad is loading...

MDGL vs SQZB

Header iconMDGL vs SQZB Comparison
Open Charts MDGL vs SQZBBanner chart's image
Madrigal Pharmaceuticals
Price$324.70
Change+$17.62 (+5.74%)
Volume$8.06K
Capitalization7.08B
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$1.05K
Capitalization884.73K
MDGL vs SQZB Comparison Chart
Loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDGL vs. SQZB commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a Hold and SQZB is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (MDGL: $307.08 vs. SQZB: $0.03)
Brand notoriety: MDGL and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 129% vs. SQZB: 6%
Market capitalization -- MDGL: $7.08B vs. SQZB: $884.73K
MDGL [@Biotechnology] is valued at $7.08B. SQZB’s [@Biotechnology] market capitalization is $884.73K. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 1 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 1 green, 4 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, both MDGL and SQZB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 3 TA indicator(s) are bullish while SQZB’s TA Score has 4 bullish TA indicator(s).

  • MDGL’s TA Score: 3 bullish, 5 bearish.
  • SQZB’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, SQZB is a better buy in the short-term than MDGL.

Price Growth

MDGL (@Biotechnology) experienced а +12.02% price change this week, while SQZB (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +2.45%, and the average quarterly price growth was -2.46%.

Reported Earning Dates

MDGL is expected to report earnings on May 13, 2025.

SQZB is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($7.08B) has a higher market cap than SQZB($885K). SQZB YTD gains are higher at: 0.000 vs. MDGL (-0.483).
MDGLSQZBMDGL / SQZB
Capitalization7.08B885K800,226%
EBITDA-502.65MN/A-
Gain YTD-0.4830.000-
P/E RatioN/AN/A-
Revenue76.8MN/A-
Total Cash999MN/A-
Total Debt119MN/A-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
29
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDGLSQZB
RSI
ODDS (%)
Bearish Trend 15 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 15 days ago
86%
Momentum
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 15 days ago
80%
MACD
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 15 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 15 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 15 days ago
77%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 23 days ago
78%
Declines
ODDS (%)
Bearish Trend 23 days ago
81%
N/A
BollingerBands
ODDS (%)
Bearish Trend 15 days ago
71%
N/A
Aroon
ODDS (%)
Bearish Trend 15 days ago
79%
Bullish Trend 15 days ago
53%
View a ticker or compare two or three
Ad is loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EQAL50.480.55
+1.10%
Invesco Russell 1000 Equal Weight ETF
VOX159.061.41
+0.89%
Vanguard Communication Services ETF
BAUG44.460.24
+0.53%
Innovator U.S. Equity Buffer ETF Aug
FXP17.82-0.35
-1.91%
ProShares UltraShort FTSE China 50
DXD25.28-0.65
-2.51%
ProShares UltraShort Dow30

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+4.58%
KANT - MDGL
62%
Loosely correlated
-2.48%
VXRT - MDGL
61%
Loosely correlated
+3.31%
ALXO - MDGL
56%
Loosely correlated
-5.17%
REPL - MDGL
55%
Loosely correlated
+16.86%
ZNTL - MDGL
51%
Loosely correlated
+0.45%
More

SQZB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SQZB has been loosely correlated with MDGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SQZB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
MDGL - SQZB
33%
Loosely correlated
+4.58%
ARRY - SQZB
33%
Loosely correlated
-4.62%
AXON - SQZB
33%
Poorly correlated
+1.97%
MIST - SQZB
31%
Poorly correlated
+8.08%
ACHL - SQZB
30%
Poorly correlated
+0.88%
More